Page 189 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Disorders of Calcium: Hypercalcemia and Hypocalcemia 179

21. Austad R, Bjerkas E. Eclampsia in the bitch. J Small Anim 43. Berndt T, Kumar R. Phosphatonins and the reg-
Pract 1976;17:793–8. ulation of phosphate homeostasis. Annu Rev Physiol
22. Bae BK, Kim CW, Choi US, Choi EW, Jee H, Kim DY, 2007;69:341–59.
et al. Hypercalcemia and high parathyroid hormone- 44. Bhang DH, Choi US, Kim MK, Choi EH, Kang MS,
related peptide concentration in a dog with a complex Hwang CY, et al. Epitheliotropic cutaneous lymphoma
mammary carcinoma. Vet Clin Pathol 2007;36(4):376–8. (mycosis fungoides) in a dog. J Vet Sci 2006;7(1):97–9.
23. BaiM,QuinnS,TrivediS,etal.Expressionandcharacteriza- 45. Bhattacharya SK, Luther RW, Pate JW, et al. Soft tissue
tion of inactivating and activating mutations in the human calcium and magnesium content in acute pancreatitis
Ca 2þ o-sensingreceptor.JBiolChem1996;271:19537–45. in the dog: calcium accumulation, a mechanism for
24. Bai M. Structure-function relationship of the extracellular hypocalcemia in acute pancreatitis. J Lab Clin Med
calcium-sensing receptor. Cell Calcium 2004;35:197–207. 1985;105:422–7.
25. Banerjee D, Asif A, Striker L, et al. Short-term, high-dose 46. Bienzle D, Jacobs RM, Lumsden JH. Relationship of
pamidronate-induced acute tubular necrosis: the serum total calcium to serum albumin in dogs, cats, horses
postulated mechanisms of bisphosphonate nephrotoxicity. and cattle. Can Vet J 1993;34:360–4.
Am J Kidney Dis 2003;41:E18. 47. Bienzle D, Silverstein DC, Chaffin K. Multiple myeloma
26. Barber PJ, Elliott J, Torrance AG. Measurement of feline in cats: variable presentation with different immunoglob-
intact parathyroid hormone: assay validation and sample ulin isotypes in two cats. Vet Pathol 2000;37:364–9.
handling studies. J Small Anim Pract 1993;34:614–20. 48. Bilezikian JP, Singer FR. Acute management of hypercal-
27. Barber PJ, Elliott J. Feline chronic renal failure: calcium cemia due to parathyroid hormone and parathyroid hor-
homeostasis in 80 cases diagnosed between 1992 and mone-related protein. In: Bilezikian JP, Levine MA,
1995. J Small Anim Pract 1998;39:108–16. Marcus R, editors. The parathyroids. New York: Raven
28. Barber PJ, Elliott J. Study of calcium homeostasis in feline Press; 1994. p. 359–372.
hyperthyroidism. J Small Anim Pract 1996;37:575–82. 49. Bilezikian JP. Clinical utility of assays for parathyroid hor-
29. Barber PJ, Rawlings JM, Markwell PJ, et al. Effect of die- mone-related protein. Clin Chem 1992;38:179–81.
tary phosphate restriction on renal secondary hyperpara- 50. Biller DS, Bradley GA, Partington BP. Renal medullary
thyroidism in the cat. J Small Anim Pract 1999;40:62–70. rim sign: ultrasonographic evidence of renal disease. Vet
30. Barber PJ, Torrance AG, Elliott J. Carboxyl fragment Radiol Ultrasound 1992;33:286–90.
interference in assay of feline parathyroid hormone. J 51. Birchard SJ, Peterson ME, Jacobson A. Surgical treatment
Vet Intern Med 1994;8:168. of feline hyperthyroidism: results of 85 cases. J Am Anim
31. Barr FJ, Patterson MW, Lucke VM, et al. Hypercalcemic Hosp Assoc 1984;20:705–9.
nephropathy in three dogs: sonographic appearance. Vet 52. Biswas PN, Wilton LV, Shakir SA. Pharmacovigilance
Radiol 1989;30:169–73. study of alendronate in England. Osteoporos Int
32. Barrett S, Sheafor SE, Hillier A, et al. Challenging cases in 2003;14:507–14.
internal medicine “What’s your diagnosis?” Vet Med 53. Black KS, Mundy GR. Other causes of hypercalcemia:
1998;93:35–44. local and ectopic secretion syndromes. In: Bilezikian JP,
33. Basoglu A, Sevinc M, Sen I, et al. The blocking effect of Marcus R, Levine MA, editors. The parathyroids. New
verapamil in hypercalcemic dogs. Turkish J Vet Anim Sci York: Raven Press; 1994. p. 341–358.
1997;21:331–3. 54. Blackwood L, Sullivan M, Lawson H. Radiographic
34. Bassett JR. Hypocalcemia and hyperphosphatemia due to abnormalities in canine multicentric lymphoma: a review
primary hypoparathyroidism in a six-month-old kitten. of 84 cases. J Small Anim Pract 1997;38:62–9.
J Am Anim Hosp Assoc 1998;34:503–7. 55. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet
35. Behrend EN, Kemppainen R. Adrenocortical disease. In: for secondary hyperparathyroidism in patients receiving
August J, editor. Consultations in feline internal medicine. hemodialysis. N Engl J Med 2004;350:1516–25.
4th ed. Philadelphia: WB Saunders; 1980. p. 159–168. 56. Blumenthal SR, Williams TC, Barbee RW, et al. Effects of
36. Bennett PF, DeNicola DB, Bonney P, et al. Canine anal sac citrated whole blood transfusion in response to hemor-
adenocarcinomas: clinical presentation and response to rhage. Lab Anim Sci 1999;49:411–7.
therapy. J Vet Intern Med 2002;16:100–4. 57. Boden SD, Kaplan FS. Calcium homeostasis. Orthop Clin
37. Bereket A, Erdogan T. Oral bisphosphonate therapy for North Am 1990;21:31–42.
vitamin D intoxication of the infant. Pediatrics 58. Body JJ, Coleman RE, Piccart M. Use of bisphosphonates
2003;111:899–901. in cancer patients. Cancer Treat Rev 1996;22:265–87.
38. Berenson J, Hirschberg R. Safety and convenience of a 15- 59. Body JJ. Clinical research update: zoledronate. Cancer
minute infusion of zoledronic acid. Oncologist 1997;80(Suppl.):1699–701.
2004;9:319–29. 60. Body JJ. Hypercalcemia of malignancy. Semin Nephrol
39. Berenson JR, Rosen L, Vescio R, et al. Pharmacokinetics 2004;24:48–54.
of pamidronate disodium in patients with cancer with nor- 61. Bolliger AP, Graham PA, Richard V, et al. Detection of
mal or impaired renal function. J Clin Pharmacol parathyroid hormone-related protein in cats with humoral
1997;37:285–90. hypercalcemia of malignancy. Vet Clin Pathol 2002;31:3–8.
40. Berger B, Feldman EC. Primary hyperparathyroidism in 62. Bourdeau A, Souberbielle JC, Bonnet P, et al.
dogs: 21 cases (1976-1986). J Am Vet Med Assoc Phospholipase-A2 action and arachidonic acid metabo-
1987;191:350–6. lism in calcium-mediated parathyroid hormone secretion.
41. Bergman SM, O’Mailia J, Krane NK, et al. Vitamin-A- Endocrinology 1992;130:1339–44.
induced hypercalcemia: response to corticosteroids. 63. Bourke E, Delaney V. Assessment of hypocalcemia and
Nephron 1988;50:362–4. hypercalcemia. Clin Lab Med 1993;13:157–81.
42. Bernardi RJ, Johnson CS, Modzelewski RA, et al. 64. Bowers Jr GN, Brassard C, Sena SF. Measurement of ion-
Antiproliferative effects of 1alpha,25-dihydroxyvitamin ized calcium in serum with ion-selective electrodes: a
D(3) and vitamin D analogs on tumor-derived endothelial mature technology that can meet the daily service needs.
cells. Endocrinology 2002;143:2508–14. Clin Chem 1986;32:1437–47.